...approach.On March 1, Genomics plc raised $30 million in a venture round from Foresite Capital, F-Prime Capital Partners...

...F-Prime CapitalCEO: Alicia SecorTARGETSHTT - Huntingtin Karen Tkach Tuzman F-Prime Capital Partners Genentech...

...in Arvelle include NovaQuest Capital Management, LSP, BRV Capital Management, Andera Partners, H.I.G. BioHealth Partners, F-Prime Capital Partners...

...fund of the American Cancer Society, as well as existing investors Sofinnova Investments, venBio Partners, F-Prime Capital Partners...
...Opdivo (Other) Checkmate Pharmaceuticals Inc. Merck & Co. Inc. Longitude Capital Decheng Capital Medicxi Ventures Omega Funds Clough Capital Partners Sectoral Asset Management Inc. F-Prime Capital Partners Novo...

...A. Investors included NovaQuest Capital Management, BRV Capital Management, LSP, H.I.G. BioHealth Partners, Andera Partners, F-Prime Capital Partners...

...by Norwest Venture Partners with participation from new investor Pivotal bioVenture Partners and existing investors F-Prime Capital Partners...

...2021. Arch Venture Partners has a 23% stake in the company ahead of the offering; F-Prime Capital Partners...

...Caufield & Byers Preclin Cancer 2015 Compass Therapeutics LLC Cambridge, Mass. $132.0 OrbiMed Advisors , F-Prime Capital Partners...
...2014 NodThera Ltd. Cambridge, U.K. $37.1 Sofinnova Partners , 5AM Ventures , Epidarex Capital , F-Prime Capital Partners...

...Undisclosed Funds raised: £28 million ($37 million) Investors: Sofinnova Partners, 5AM Ventures, Epidarex Capital and F-Prime Capital Partners...